Description
General Description
PEI-g-PEG-N3 combines the strong nucleic acid binding capability of PEI with the stealth and biocompatibility benefits of PEG. The cationic PEI backbone efficiently complexes DNA, mRNA, siRNA, plasmids, oligonucleotides, and CRISPR components through electrostatic interactions.
PEG grafting reduces the cytotoxicity typically associated with PEI, improves aqueous solubility, minimizes aggregation, and enhances colloidal stability. The terminal azide groups provide a versatile platform for bioorthogonal conjugation through copper-catalyzed azide-alkyne cycloaddition (CuAAC) and strain-promoted azide-alkyne cycloaddition (SPAAC).
PEI-g-PEG-N3 is commonly used for targeted gene delivery systems, nanoparticle surface engineering, antibody conjugation, peptide conjugation, molecular imaging, and advanced nanomedicine applications.
Applications
- Gene delivery
- DNA transfection
- mRNA delivery
- siRNA delivery
- CRISPR delivery
- Click chemistry conjugation
- Nanoparticle functionalization
- Antibody conjugation
- Targeted drug delivery
- Biomaterials research
Features and Benefits
- Efficient nucleic acid complexation
- Reduced PEI-associated cytotoxicity
- Improved aqueous solubility
- Enhanced colloidal stability
- Reactive azide functionality
- Compatible with CuAAC and SPAAC chemistry
- Suitable for nanoparticle engineering
- Excellent surface modification capability
- Available in multiple PEI and PEG molecular weights








